ArticleAntibiotics (Basel, Switzerland)2022

Targeting SAM-I Riboswitch Using Antisense Oligonucleotide Technology for Inhibiting the Growth of

Martina Traykovska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.